Thomas Cope
@tccambs
Neurologist specialising in neuropsychiatry, cognition and epilepsy. Systems neuroscientist interested especially in prediction and language.
ID: 938485337344626688
06-12-2017 19:08:35
169 Tweet
307 Followers
89 Following
The fantastic Robert Howard again highlighting something I hadn't considered. The potential for infusion reactions unblinding patients and relatives during the lecanemab trial, perhaps contributing to very small clinical effects. British Neuropsychiatry Association fantastic conference.